# Omabit **Source:** https://www.startuphub.ai/startups/omabit **Profile type:** Startup > AI for life science R&D, turning R&D data into answers for pharma and biotech teams. ## About Omabit provides an AI-driven platform for life science R&D, enabling biologists and researchers to upload sequencing files and receive structured, reproducible genomic analysis results without writing code. The platform analyzes clinical, genomic, and other R&D data, checks findings against published research, and generates write-ups with the underlying code. It is used by pharma and biotech teams, from the lab to Phase 2 trials, to accelerate analysis from months to days. ## Key facts - **Slug:** omabit - **Website:** https://omabit.com - **Location:** Palo Alto, United States - **Founded:** 2025-01-01 - **Operating status:** Active - **Total funding:** $2M - **Sectors / tags:** AI Drug Discovery, Genomics, Biotech, MedTech, HealthTech ## StartupHub.ai scores - **Ahrefs DR:** 1/100 - **Agent Readiness:** D (47/100) - **Site Speed:** 90/100 - **Data Trust:** 56/100 ## Funding rounds | Date | Round | Amount | Lead investors | | --- | --- | --- | --- | | 27 Oct 2026 | [Seed](https://www.startuphub.ai/investment_rounds/omabit-seed-2026) | $2.0M | - | ## Tech stack Detected on omabit.com, last scanned 2026-10-27. - **Compliance:** SOC 2 - **CDN:** Cloudflare - **Email provider:** Google Workspace ## JSON-LD Structured data aligned with this page's `